Company profile for Unum Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

For too long, people have lived with the fear and uncertainty of a cancer diagnosis, creating a sense of helplessness and hopelessness. We at Unum know that the only course of action, the only way to eliminate the fear and uncertainty of cancer is to transform the treatment paradigm. Our team comes to work each day driven by that opportunity and a sense of urgency to deliver novel cell therapies to cure cancer and provide new ...
For too long, people have lived with the fear and uncertainty of a cancer diagnosis, creating a sense of helplessness and hopelessness. We at Unum know that the only course of action, the only way to eliminate the fear and uncertainty of cancer is to transform the treatment paradigm. Our team comes to work each day driven by that opportunity and a sense of urgency to deliver novel cell therapies to cure cancer and provide new hope to patients and their families. Unum scientists have engineered our ACTR and BOXR platform technologies to improve the functionality of T cells and more effectively target and kill cancer cells.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
200 Cambridge Park Drive Suite 3100 | Cambridge, MA 02140
Telephone
Telephone
+1.617.945.5576
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Clinical Outsourcing

Clinical Outsourcing

Not Confirmed

envelop Contact Supplier

Clinical Outsourcing

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.reuters.com/article/us-unum-software-vaccines/unum-to-launch-vaccine-verification-tool-for-companies-to-manage-federal-mandate-idUSKBN2GC27G

REUTERS
16 Sep 2021

https://www.prnewswire.com/news-releases/unum-therapeutics-announces-company-name-change-to-cogent-biosciences-highlights-recent-scientific-and-operational-progress-301145637.html

PRNEWSWIRE
05 Oct 2020
Unum's CAR-T tech lands at Czech biotech Sotio in $8.1M deal
Unum's CAR-T tech lands at Czech biotech Sotio in $8.1M deal

31 Aug 2020

// Amirah Al Idrus FIERCEBIOTECH

https://www.fiercebiotech.com/biotech/unum-s-car-t-tech-and-research-team-lands-at-czech-biotech-sotio-for-8-1m

Amirah Al Idrus FIERCEBIOTECH
31 Aug 2020

https://www.contractpharma.com/contents/view_breaking-news/2020-08-31/sotio-acquires-rights-to-boxr-cell-therapy-platform/

CONTRACTPHARMA
31 Aug 2020

https://www.globenewswire.com/news-release/2020/08/31/2086052/0/en/SOTIO-Acquires-Rights-to-BOXR-CAR-T-Platform-and-Products-from-Unum-Therapeutics.html

GLOBENEWSWIRE
31 Aug 2020

https://endpts.com/investors-give-ailing-unum-a-lease-on-life-and-a-whole-new-suite-of-experimental-cancer-drugs/

Jason Mast ENDPTS
07 Jul 2020

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty